User profiles for M. Brzosko
Marek Brzoskoprofesor medycyny Verified email at pum.edu.pl Cited by 3565 |
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double‐blind treatment phase …
Objective To assess the efficacy and safety of tocilizumab plus methotrexate (MTX) versus
MTX alone in preventing structural joint damage and improving physical function and disease …
MTX alone in preventing structural joint damage and improving physical function and disease …
Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis
…, M Maradiaga, C Pacheco, M Brzosko… - Arthritis & …, 2019 - Wiley Online Library
Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐controlled
studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included patients …
studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included patients …
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the …
W Park, DH Yoo, P Miranda, M Brzosko… - Annals of the …, 2017 - ard.bmj.com
… Marek Brzosko4, … PM, MB, PW, SG-U, HM, Y-AL, SS, M-JL, VK and CA-M were involved
in the acquisition of data, drafting of the manuscript and revising it critically for important …
in the acquisition of data, drafting of the manuscript and revising it critically for important …
[PDF][PDF] Biosimilar switching–current state of knowledge
Evidence from over 10 years of clinical experience demonstrates that biosimilar medicines
approved in the European Union can be used for all their registered indications as safely as …
approved in the European Union can be used for all their registered indications as safely as …
[HTML][HTML] The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis
A Pawlik, L Ostanek, I Brzosko, M Brzosko, M Masiuk… - Arthritis Res Ther, 2003 - Springer
Clonal expansion of CD4 + CD28 - T cells is a characteristic finding in patients with rheumatoid
arthritis (RA). Expanded CD4 + clonotypes are present in the peripheral blood, infiltrate …
arthritis (RA). Expanded CD4 + clonotypes are present in the peripheral blood, infiltrate …
SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review
H Przepiera-Będzak, M Brzosko - Advances in Dermatology and …, 2021 - termedia.pl
… Przepiera-Będzak H, Brzosko I, Brzosko M. Skeletal changes during the course of
pustulosis palmoplantaris – report of two cases. Pol Arch Med Wewn 2002; 107: 59-62. …
pustulosis palmoplantaris – report of two cases. Pol Arch Med Wewn 2002; 107: 59-62. …
Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
…, G Poór, P Wiland, M Olejárová, M Brzosko… - The European Journal of …, 2014 - Springer
Biological drugs revolutionized the treatment of inflammatory rheumatic diseases. Access to
treatment presents substantial variability across Europe. The economic level of a particular …
treatment presents substantial variability across Europe. The economic level of a particular …
Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE …
RM Fleischmann, AM Halland, M Brzosko… - The Journal of …, 2013 - jrheum.org
… M. Brzosko has received lecture/instructor fees from Roche, Abbott, Amgen, Pfizer, MSD,
Novartis, Schering-Plough, and Sanofi-Aventis. R. Burgos-Vargas has received research grants …
Novartis, Schering-Plough, and Sanofi-Aventis. R. Burgos-Vargas has received research grants …
[HTML][HTML] Serum IL-6 and IL-23 levels and their correlation with angiogenic cytokines and disease activity in ankylosing spondylitis, psoriatic arthritis, and SAPHO …
H Przepiera-Będzak, K Fischer, M Brzosko - Mediators of inflammation, 2015 - hindawi.com
… Hanna Przepiera-Będzak and Marek Brzosko conceived the idea for the study, contributed
to the design of the research, were involved in data collection, and analyzed the data. Hanna …
to the design of the research, were involved in data collection, and analyzed the data. Hanna …
[HTML][HTML] Factors associated with quality of life in systemic sclerosis: a cross-sectional study
…, A Grabowska-Jodkowska, M Brzosko… - Quality of Life …, 2019 - Springer
Introduction Systemic sclerosis (SSc) is a connective tissue disease characterized by progressive
fibrosis of the skin and internal organs, leading to their failure and disturbances in the …
fibrosis of the skin and internal organs, leading to their failure and disturbances in the …